Pharsight

Zydus patents expiration

1. Zituvio patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10925871 ZYDUS Pharmaceutical compositions of sitagliptin
Feb, 2035

(10 years from now)

Drugs and Companies using SITAGLIPTIN ingredient

Market Authorisation Date: 18 October, 2023

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

ZITUVIO family patents

Family Patents